A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration.

Autor: Singh, Ramandeep1 (AUTHOR), Chauhan, Rohan2 (AUTHOR), Saxena, Ashish3 (AUTHOR), Shah, Anup4 (AUTHOR), Mondal, Laxshmi5 (AUTHOR), Bakhle, Dhananjay6 (AUTHOR), Shah, Chirag6 (AUTHOR), Shah, Arpit6 (AUTHOR), Deoghare, Shashank6 (AUTHOR), Krishnan, Neelakant6 (AUTHOR), Godse, Neelima6 (AUTHOR)
Zdroj: Indian Journal of Ophthalmology. Aug2022, Vol. 70 Issue 8, p3008-3014. 7p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje